PFC LTD data by sex
| Condition | Test – measure (unit) | Value | t test (M vs F) |
|---|---|---|---|
| Sham male | eCB-LTD – normalized fEPSP (35–40 min post-tetanus) | 80.61 ± 3.408 N = 8 | p = 0.5478 |
| Sham female | eCB-LTD – normalized fEPSP (35–40 min post-tetanus) | 83.90 ± 4.061 N = 6 | |
| WIN male | eCB-LTD – normalized fEPSP (35–40 min post-tetanus) | 103.9 ± 8.384 N = 6 | p = 0.7042 |
| WIN female | eCB-LTD – normalized fEPSP (35–40 min post-tetanus) | 108.8 ± 9.488 N = 7 | |
| Sham male | mGlu2/3-LTD – normalized fEPSP (35–40 min postdrug) | 66.26 ± 4.196 N = 6 | p = 0.8390 |
| Sham female | mGlu2/3-LTD – normalized fEPSP (35–40 min postdrug) | 67.58 ± 4.700 N = 6 | |
| WIN male | mGlu2/3-LTD – normalized fEPSP (35–40 min postdrug) | 67.48 ± 4.156 N = 7 | p = 0.4467 |
| WIN female | mGlu2/3-LTD – normalized fEPSP (35–40 min postdrug) | 72.00 ± 3.900 N = 5 |